Holen Sie sich die Stockscreener-App
89.79
1.09%
-0.99
Handel nachbörslich:
89.79
Schlusskurs vom Vortag:
$90.78
Offen:
$91.05
24-Stunden-Volumen:
173.71K
Relative Volume:
0.38
Marktkapitalisierung:
$1.95B
Einnahmen:
$486.82M
Nettoeinkommen (Verlust:
$18.78M
KGV:
109.50
EPS:
0.82
Netto-Cashflow:
$100.45M
1W Leistung:
+0.17%
1M Leistung:
-7.87%
6M Leistung:
+37.88%
1J Leistung:
+62.96%
1-Tages-Spanne:
$89.31
$91.47
1-Wochen-Bereich:
$89.13
$92.56
52-Wochen-Spanne:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
Ani Pharmaceuticals Inc
Sektor
Telefon
(218) 634-3500
Adresse
210 MAIN STREET WEST, BAUDETTE, MN
Vergleichen Sie ANIP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
89.79 | 2.02B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-03-12 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-15 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-02 | Eingeleitet | Truist | Buy |
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy |
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy |
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold |
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy |
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral |
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral |
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform |
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Bestätigt | ROTH Capital | Buy |
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform |
Alle ansehen
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Is ANI Pharmaceuticals Inc. a candidate for recovery play2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Truist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price - MarketBeat
Visualizing ANI Pharmaceuticals Inc. stock with heatmaps2025 Price Targets & Weekly High Momentum Picks - newser.com
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance
ANI Pharmaceuticals Inc. stock trend forecastTrade Signal Summary & Daily Technical Forecast Reports - newser.com
What recovery options are there for ANI Pharmaceuticals Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
Will a bounce in ANI Pharmaceuticals Inc. offer an exitQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
How ANI Pharmaceuticals Inc. (BSFA) stock compares with tech leaders2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Analyzing recovery setups for ANI Pharmaceuticals Inc. investors2025 Year in Review & Technical Confirmation Trade Alerts - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock beat value stocksQuarterly Profit Report & Pattern Based Trade Signal System - newser.com
Is ANI Pharmaceuticals Inc. stock undervalued vs historical averages2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com
ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings - MarketBeat
ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q2 Earnings? - Barchart.com
ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail
Can ANI Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Institutional scanner results for ANI Pharmaceuticals Inc.Bond Market & Low Drawdown Trading Strategies - newser.com
Can ANI Pharmaceuticals Inc. stock sustain revenue growth2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Live market analysis of ANI Pharmaceuticals Inc.Weekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Is a relief rally coming for ANI Pharmaceuticals Inc. holdersWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
What moving averages say about ANI Pharmaceuticals Inc.Short Setup & Fast Gain Stock Trading Tips - newser.com
A Fresh Look at ANI Pharmaceuticals (ANIP) Valuation as Quiet Market Moves Draw Investor Interest - Yahoo Finance
What analysts say about ANI Pharmaceuticals Inc stockLong-Term Investment Plans & Swing Trade Smarter With Data Insights - earlytimes.in
Assenagon Asset Management S.A. Sells 101,728 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ani Pharmaceuticals Inc-Aktie (ANIP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. |
Sep 12 '25 |
Sale |
98.42 |
400 |
39,368 |
76,074 |
| Pera Antonio R | Director |
Sep 03 '25 |
Sale |
94.94 |
7,292 |
692,302 |
22,660 |
1.54%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):